🇺🇸 FDA
Pipeline program

Sodium Oxybate

47852

Approved small_molecule completed

Quick answer

Sodium Oxybate for REM Sleep Behavior Disorder is a Approved program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
REM Sleep Behavior Disorder
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials